Loading…
Loading…
VRTX · NASDAQ · Healthcare
Year-to-date total return including price appreciation. Compare performance against the S&P 500 benchmark.
Market Cap
$114.58B
P/E Ratio
28.98
Forward P/E
—
EPS
$15.46
PEG Ratio
0.88
Book Value
$73.00
Dividend Yield
—
Profit Margin
32.94%
ROE
21.18%
Use the interactive ytd return with pre-loaded data for Vertex Pharmaceuticals Inc. Adjust discount rates, growth assumptions, and projection horizons to model different scenarios.
Pre-loaded inputs for VRTX: